Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.

Abstract

BACKGROUND A prolonged-release formulation of tacrolimus for once-daily administration (Tacrolimus QD) has been developed to offer potential improvements in patient adherence. This study compared the pharmacokinetics (PK) of tacrolimus in stable kidney transplant recipients before and after conversion from twice-daily tacrolimus (Tacrolimus BID) to… (More)
DOI: 10.1097/FTD.0b013e318244a7fd

Topics

Cite this paper

@article{Hooff2012PharmacokineticsIS, title={Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.}, author={Johannes P. van Hooff and Isak Van der Walt and Jeffrey Kallmeyer and Derek Miller and Shabbir Dawood and Mohammed Rafique Moosa and Maarten H. L. Christiaans and Carmen Karpf and Nasrullah Undre}, journal={Therapeutic drug monitoring}, year={2012}, volume={34 1}, pages={46-52} }